undamentalytics Newsletter

Solventum balance sheet

At the end of fiscal 2025, Solventum had total assets of $14.29bn, total liabilities of $9.24bn and shareholders' equity of $5.05bn. It held $878m in cash against $5.08bn of debt: net debt of $4.21bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Solventum: balance sheet, annual
Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents0.10.20.80.90.4
Receivables—1.31.01.01.3
Inventory—0.91.01.11.0
Total current assets—2.53.23.93.7
Goodwill6.46.56.45.75.6
Total assets—13.914.514.314.2
Accounts payable—0.50.60.70.7
Deferred revenue (current)—0.60.60.60.6
Total current liabilities—1.72.73.13.7
Short-term debt—0.00.20.00.5
Long-term debt—0.07.85.04.6
Total debt0.00.08.15.15.1
Total liabilities—2.311.59.29.4
Shareholders' equity11.711.73.05.04.8
Net debt (negative = net cash)−0.1−0.27.34.24.7
Shares outstanding——173m173m170m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: SOLV vs VEEVSOLV vs TDOCSOLV vs TEM

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Solventum's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Solventum.